Literature DB >> 6101353

Intrapleural BCG in operable lung cancer.

J Lowe, P B Iles, D F Shore, M J Langman, R W Baldwin.   

Abstract

In a controlled randomised clinical trial of 92 patients with surgically resected lung cancer, intrapleural BCG had no clear effect on survival. Adverse effects were insignificant.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6101353     DOI： 10.1016/s0140-6736(80)90551-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  9 in total

1.  Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.

Authors:  W Bakker; J M Nijhuis-Heddes; E A van der Velde
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 2.  Manipulation of host resistance in cancer therapy.

Authors:  R W Baldwin
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosis.

Authors:  M Markman
Journal:  West J Med       Date:  1985-07

4.  Distribution of intrapleural and intravenous Corynebacterium parvum in humans; 99mTc-, and 131I-labeled bacteria.

Authors:  M Kaufmann; J Marqverson; K E Stanley; C Mouritzen; H Hvid-Hansen
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma. Analysis at the eighth year.

Authors:  H Takita; A Hollinshead; T Hart; J Bhayana; R Adler; U Rao; R Moskowitz; M Ramundo
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.

Authors:  W Bakker; J M Nijhuis-Heddes; A M Wever; A Brutel de la Rivière; E A van der Velde; J H Dijkman
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

7.  Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.

Authors:  N Roeslin; J M Lang; G Morand; J M Wihlm; J P Witz
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

8.  Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.

Authors:  B Z Ngwenya; N Yamamoto
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.

Authors:  A C Hollinshead; T H Stewart
Journal:  Yale J Biol Med       Date:  1981 Sep-Oct
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.